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Abstract
Canine parvovirus (CPV) is an emerged pathogen in dogs, first isolated
in 1978 in the USA. The original 1978 strain was designated CPV type
2 (CPV-2). However, analysis of  CPV isolates in the USA by restriction
enzymes and monoclonal antibodies have shown that around the
year 1979 a CPV variant strain, designated CPV type 2a (CPV-2a),
became widespread. Subsequently, a new antigenic strain, designated
CPV type 2b (CPV-2b), was also observed by analysis of  CPV isolates
from various parts of the world, although the proportion of each
strains was different between countries. In this study, the
Haemagglutination Inhibition (HI) test with a panel of  monoclonal
antibodies was used to type canine parvovirus strains in 29 fecal
samples collected from symptomatic dogs from 1980 to 1986 and
from 1990 to 1995. The results showed a strong predominance of
the antigenic type 2a indicating that the CPV epizooty in Brazil followed
the same pattern observed in European and Asian countries.
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Introduction
Since 1978, a dog epizooty of an
unknown disease was observed in many
parts of the world.1,2,3,4,5 This disease usually
caused death by miocarditis in young dogs
or hyperthermia followed by emetic
episodes and / or diarrhea in adult canides.
The enteritis and pathological traits were very
similar to those observed in cats infected by
Feline Panleucopenia Virus (FPV). Soon, a
strict relationship between this etiological
agent and the FPV was recognized. 2,3,6
The original 1978 strain was
designated CPV type 2 (CPV-2) to
distinguish it from the previously recognized
canine parvovirus known as minute virus of
canides.7 Around 1979, a variant CPV strain,
designated CPV 2a (CPV-2a) became
widespread and replaced the original strain
from 1980 to 1981 in the USA.8 Analysis of
CPV isolates by monoclonal antibodies and
restriction enzymes, since 1984 in the USA,
identified another antigenic variant,
designated CPV type 2b (CPV-2b).9 The
same pattern of  spreading of  the CPV-2 and
the subsequent replacement by new antigenic
strains was observed in Germany, Denmark,
Japan, France, Australia, and Spain, although
the proportion of  CPV-2a and CPV-2b was
different in those countries.10,11,12,13,14 The
sequential evolution of new antigenic types
(antigenic drift) appears uncommon but has
been studied extensively using monoclonal
antibodies and molecular analysis as a feature
of  the epidemiology and evolution of  canine
parvovirus 13,15,16,17,18,19,20,21  and influenza virus
isolates 22,23,24,25.
Recently, researches described a
new antigenic variant, termed CPV-2c.26
Although the genetic variants between the
isolates of  CPV-2c from Vietnam, Taiwan,
Italy and Spain differ by only a small number
of amino acids, there are also implications
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for vaccine efficacy because vaccines based
on older variants may not protect against
newer variants.26,27
In Brazil, CPV-like infections were
first observed in 1979 and diffusion of  the
virus occurred since 1980.28 Pereira et al.29
designed a Polymerase Chain Reaction (PCR)
assay to type canine parvovirus strains in fecal
samples collected from symptomatic dogs
from 1980 to 1986 and from 1990 to 1995.
Genetic analysis showed that the CPV
epizooty in Brazil followed the same pattern
observed in the USA: emergence of  CPV-2
followed by replacement by the variants
CPV-2a and 2b. The predominant strain
found in 1980 was CPV-2a, which was
substantially replaced by CPV-2b from 1990
to 1995. The same analysis was also applied
to show that CPV-2b was the most
prevalent type circulating in the State of Rio
de Janeiro from 1995 to 2001.30 Despite the
previous genetic characterization of Brazilian
CPV strains, there was a lack of data
concerning the antigenic characterization of
CPV strains in Brazil.
The aim of this study was to
characterize antigenically the CPV found in
29 fecal samples from clinically ill dogs from
Brazil, from 1980 to 1986 and 1990 to 1995.
Materials and Methods
In this study, a total of  29 fecal
samples from clinically ill dogs collected
from various areas of Brazil, from 1980 to
1986 and 1990 to 1995, were characterized
by the haemagglutination inhibition (HI) test
using a panel of monoclonal antibodies
(MAb) as previously described.31 The
presence of  CPV was previously confirmed
by demonstration of  haemagglutination
(HA), isolation of the virus in tissue culture
(CC), electron microscopy (EM), enzyme
linked immunosorbant assay (ELISA) or
PCR.29,32 The prototype strains of  CPV-2
(CPV-d), CPV-2a (CPV-15) and CPV-2b
(CPV-39) and monoclonal antibodies (A4E3,
C1D1, C7D6 and B4A2) were kindly
provided by Dr. C. R. Parrish (Cornell
University, Ithaca, N.Y.).
Briefly, porcine erythrocytes were
collect in Alsever´s solution, and stored at 4
0C for at least 24 hours before use.
Erythrocytes were washed three times in
PBSS (0.015 M phosphate buffer, 0.9%
NaCl, pH 7.0) and were suspended to 1%
(v/v) in PBS containing 0.1% bovine serum
albumin. Fecal specimens from field animals
were suspended in nine parts of parts of
ice-cold PBS and agitated vigorously for 1
minute. Suspensions were centrifuged
(12.000 g) at 4 0C for 60 minutes and the
supernatant were tested for HA activity. Tests
were performed in 96-well plastic V-plates.
For HA tests, serial two-fold dilutions (0.05
ml) of fecal solutions were prepared from
initial 1:2 dilution. An equal volume of ice-
cold porcine RBC suspension was added to
each well and plates were incubated at 4 0C
for 2 to 4 hours. For HI testes twofold serial
dilution of monoclonal antibodies (MAb)
A4E3, C1D1, C7D6 and B4A2 were made
in V-bottom plastic plates. To each Mabs
dilution was added 0.025 ml of HA antigen
that contained 8 HA units. After 1 hour at
room temperature, 0.05 ml of the
appropriate chilled erythrocyte suspension
was added and plates were incubated at 4
0C for 4 to 16 hours until erythrocyte controls
had formed clear buttons. Low or no titer
with C1D1 indicates that the virus is type 2.
High titered reaction with C1D1 and C7D6
indicates that the virus is either a type-2a or
type-2b. Low titer (< 4) with B4A2 indicates
that the virus is a type-2b. Reaction with
A4E3 indicate that virus is a CPV strain, either
type-2, type-2a or type-2b.
Results and Discussion
The epidemiological history of CPV
in Brazil resembled in many aspects that seen
in other countries, where frequency shifts on
antigenic types were reported.9,11,12,13,33,34
Herein, the results of the antigenic
characterization by the HI assay showed that
all samples were characterized as CPV-2a,
except for one, collected in 1995,
characterized as CPV type 2.
It is interesting to note an apparent
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disagreement with previous studies using the
PCR assay29, 30 regarding the predominant
strain that replaced the original CPV-2 in
Brazilian samples.
However, PCR, as well as restriction
site mapping analysis, detect point mutations
in specific genome regions not necessarily
related to phenotypic changes that lead to
antigenic variation. On the other hand,
nucleotide sequence followed by phylogenetic
analyses of large regions of the genome
improves molecular characterization,
particularly in genome regions under evolutive
pressure such as the VP1 and VP2 genes of
CPV.9,34,35,36
Indeed, analysis of 31 sequences of
the VP1/VP2 gene obtained from
symptomatic domestic dogs in Brazil,
sampled from 1980 to 2000, used to
evaluate evolutionary changes in CPV,
revealed that CPV type 2a was the
predominant antigenic type circulating in
Brazil 37, which agrees with our results.
Although these data have restricted
epidemiologic meaning, it is important to
emphasize the complete lack of  information
concerning antigenic phenotypic
characteristics of CPV in Brazil. Carnivore
parvoviruses have continuously evolved since
CPV-2a/2b-related strains were isolated in
domestic cats as well as a new antigenic type,
designated CPV type 2c, was detected in
wildcats.38,39,40 The interspecies transmission
seems to be more complex since CPV-2c
was recently isolated in domestic dogs 26 and
more studies will be required to address this
question.
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Caracterização antigênica de isolados de parvovirus canino do Brasil
utilizando monoclonais específicos
Resumo
O Parvovírus Canino (CPV) é um patógeno emergente em cães, isolado
pela primeira vez em 1978, nos Estados Unidos. A amostra original de
1978 foi designada CPV tipo 2 (CPV-2). Entretanto, análises de isolados
de CPV dos Estados Unidos, por enzimas de restrição e anticorpos
monoclonais demonstraram que cerca de 1979, uma amostra variante,
designada CPV tipo 2a (CPV-2a) tornou-se prevalente. Subseqüentemente,
uma nova amostra antigênica, designada CPV tipo 2b (CPV-2b) também
foi observada por análises de isolados de CPV de várias partes do mundo,
embora a proporção fosse diferente entre os países. Nesse estudo, foi
utilizado o teste de Inibição da Hemaglutinação (HI) com um painel de
anticorpos monoclonais para a tipagem de 29 amostras fecais de
parvovirus canino, coletadas de cães sintomáticos de 1980 a 1986 e de
1990 a 1995. Os resultados indicaram uma forte predominância do tipo
antigênico 2a indicando que a epizootia de CPV no Brasil seguiu o
mesmo padrão observados na Europa e países Asiáticos.
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